Renewable Energy Stocks Q4 Highlights: TPI Composites (NASDAQ:TPIC)
Looking back on renewable energy stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including TPI Composites (NASDAQ:TPIC) and its peers.
3 Reasons AME is Risky and 1 Stock to Buy Instead
AMETEK currently trades at $177.60 per share and has shown little upside over the past six months, posting a middling return of 3.7%.
Q4 Earnings Recap: Lindsay (NYSE:LNN) Tops Agricultural Machinery Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at agricultural machinery stocks, starting with Lindsay (NYSE:LNN).
Spotting Winners: eHealth (NASDAQ:EHTH) And Online Marketplace Stocks In Q4
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how eHealth (NASDAQ:EHTH) and the rest of the online marketplace stocks fared in Q4.
Real Estate Services Stocks Q4 Teardown: Marcus & Millichap (NYSE:MMI) Vs The Rest
Let’s dig into the relative performance of Marcus & Millichap (NYSE:MMI) and its peers as we unravel the now-completed Q4 real estate services earnings season.
3 Reasons TKR is Risky and 1 Stock to Buy Instead
Over the last six months, Timken’s shares have sunk to $76.64, producing a disappointing 6.7% loss while the S&P 500 was flat. This might have investors contemplating their next move.
3 Reasons to Sell CHDN and 1 Stock to Buy Instead
Over the past six months, Churchill Downs’s stock price fell to $112.83. Shareholders have lost 14.4% of their capital, disappointing when considering the S&P 500 was flat. This may have investors wondering how to approach the situation.
Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers.
3 Reasons to Sell RPD and 1 Stock to Buy Instead
Over the past six months, Rapid7’s shares (currently trading at $29.56) have posted a disappointing 16.7% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Data & Business Process Services Stocks Q4 Teardown: Planet Labs (NYSE:PL) Vs The Rest
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Planet Labs (NYSE:PL) and the rest of the data & business process services stocks fared in Q4.